The US Oncology Network in the News

In the News

Read about us in the news to learn how the more than 1,200 physicians in The US Oncology Network advance cancer care in America.

Broadcast/Video

OncLive: Dr. Monk on the Utility of Tisotumab Vedotin in Recurrent Cervical Cancer

Investigating Combinations in Recurrent or Metastatic Cervical Cancer

A Breast Cancer Roundtable: CDK4/6 Inhibition, HER2-Positive Disease, and the Role of Immunotherapy

Advanced Breast Cancer: Expert Perspectives On Recent Progress

Dr. Burke on Current FDA Indications for BTK Inhibitors in B-Cell Malignancies

Provider Responsibility to Cost Burden for mBC Therapy

Patient Journey and Development of Metastatic Breast Cancer

OncologyTube: RWE on the Impact in the Oncology Community

OncLive: Classification of Triple Negative Breast Cancer

Oncology Times: Oncology Care Model Supports Practice & Benefits Medicare’s Bottom Line

Oncology Times: Measuring Quality of Cancer Care in Changing Health Care Landscape

KGW-TV 8: Portland woman finds success in clinical trial for breast cancer

OncLive: ESMO 2019: Dr. O’Shaughnessy Highlights Progress in Breast Cancer

Oncology Business Review: Joyce O’Shaughnessy, MD, on differentiating CDK4/6 inhibitors

Oncology Business Review: Joyce O’Shaughnessy, MD, on the role of CDK4/6 inhibitors in the management of TNBC

Oncology Business Review: Ira Zackon, MD, explains how medically integrated pharmacies collaborate to provide quality care

Oncology Business Review: Ira Zackon, MD, offers opinion on specialty pharmacies and payer requirements

Oncology Business Review: Ira Zackon, MD, elaborates on medically integrated pharmacies

Medscape: Guiding Patients To and Through Second Opinions

Oncology Business Review: Ira Zackon, MD, offers perspective on the advantages of medically integrated pharmacies

OncLive: Dr. Sharman on the Potential Future of Acalabrutinib in CLL 

Healio: Oncology care model enhances quality, increases value

OncologyTube: MAGNIFY Study: Phase 3 Study Of Lenalidomide (Revlimid) Plus Rituximab (Rituxan) Followed By Maintenance Therapy In Relapsed/Refractory NHL

OncologyTube: Trial Updates at ASCO: Approval of Daratumumab in Combination With Revlimid Or Velcade & Dexamethasone

OncologyTube: Isatuximab & Daratumumab: When You Add Isatuximab TO Pomalidomide & Dexamethasone Outcomes Are A Lot Better

OncologyTube: Connect MM Myeloma Disease Registry: This Is A Special Group Of Myeloma Patients Because They Respond To Venetoclax

OncologyTube: Measuring BCMA: Do Not Have To Wait For Relapse, We Know When The Disease Has Become Resistant

OncologyTube: Debra Patt MD of US Oncology Research Discusses Using A.I. & Predictive Analytics In Healthcare: Will Augment Physicians Decisions As Opposed To Replace Them & Provide Appropriate Choice Architecture

OncologyTube: Debra Patt MD of US Oncology Research Discusses Delivering Innovated Care In The Clinic: Innovations Made In The Clinic Have Been Transformative In Terms of Improving The Quality & Value Of Care For Patients

OncologyTube: Mark Fleming MD of US Oncology Research Discusses TITAN Trial: Many Options Including Chemo, Abiraterone, Enzalutamide, & Apalutamide All Showing A Benefit

OncologyTube: Mark Fleming MD of US Oncology Research Discusses Treatment Sequencing for Castrate Resistant M0 Disease: Looking at 3 Drugs Enzalutamide, Apalutamide, & Darolutamide, The Options Are The Challenge

OncologyTube: Neelima Denduluri MD of US Oncology Research Discusses Updates on Patient Care from ASCO: New Ways to Educate Patients Like Micro-learning Videos, Analysis About Cost-Effective Breast Cancer Screening

OncologyTube: MONALEESA-7 Trial in Premenopausal Metastatic Breast Cancer

OncologyTube: ImPassion130 Trial Outcomes

OncologyTube: EMBRACA Trial in HER2 Metastatic Breast Cancer

OncologyTube: Data on SOPHIA Trial in HER+ Metastatic Breast Cancer

The Video Journal of Oncology: Multiple treatment options for prostate cancer

The Video Journal of Oncology: ASCO 2019 | What to expect in prostate cancer therapy in the future

Onco’Zine: Growing Importance of Community Oncologists in Clinical Research Evidenced by Large Number of Presentations at ASCO 2019

Cancer Therapy Advisor: Advanced Soft Tissue Sarcomas: Dox + Olaratumab vs. Dox + PBO

Healio: CDK 4/6 Inhibitors Help Make Advanced Breast Cancer ‘Chronic Disease’ For Many Patients

Medscape: From Oncology Care to Primary Care: Reassuring Survivors

OncLive: OncLive News Network On Location: In Chicago Saturday, June 1

Oncology Business Review: Neelima Denduluri, MD, regarding the MONALEESA-7 trial in premenopausal metastatic breast cancer

Oncology Business Review: Neelima Denduluri, MD, discusses outcomes from the ImPassion130 trial

Oncology Business Review: Neelima Denduluri, MD, regarding the EMBRACA trial in HER2- metastatic breast cancer

Oncology Business Review: Neelima Denduluri, MD, elaborates on the SOPHIA trial data in HER+ metastatic breast cancer

Oncology Business Review: Debra Patt, MD, MPH, MBA, on the important implications of the MONDALEESA-7 trial

Oncology Business Review: Debra Patt, MD, MPH, MBA, regarding the implications of the ImPassion130 trial in TNBC

Oncology Business Review: Debra Patt, MD, MPH, MBA, considers the role of CDK 4/6 inhibitors in advanced breast cancer

Oncology Business Review: Debra Patt, MD, MPH, MBA, on the factors influencing cost in novel therapeutic interventions

Oncology Business Review: Debra Patt, MD, MPH, MBA, considers the transition from volume to value in the oncology space

Oncology Business Review: Debra Patt, MD, MPH, MBA, outlines policies proposed to address drug pricing

Oncology Business Review: Robert M. Rifkin, MD, FACP, discusses outcomes from the ECOG trial in smolder multiple myeloma

Oncology Business Review: Robert M. Rifkin, MD, FACP, explains how isatuximab differs from daratumumab

Oncology Business Review: Robert M. Rifkin, MD, FACP, considers progression-free survival in MM when treating with isatuximab

Oncology Business Review: Robert M. Rifkin, MD, FACP, discusses maintenance regimens for multiple myeloma

OncLive: Dr. Nadler on the Impact of Immunotherapy in Squamous NSCLC

UroToday: The Changing Therapeutic Landscape of Prostate Cancer-Nicholas Vogelzang

Oncology Business Review: Ben Jones considers recent policy changes of which oncologists should be aware

Oncology Business Review: Ben Jones offers his opinion on priority policy concerns

OncLive: Dr. O’Shaughnessy on Clinical Implications of the TEXT and SOFT Trials in Breast Cancer

Patient Power: Is Chemo Safe for CLL Patients With a 17p Deletion?

OncLive: Dr. Fleming Discusses Importance of QoL in Prostate Cancer

Oncology Business Review: Mark T. Fleming, MD, regarding the implications of the CHECKMATE 650 study presented at GU 2019

Oncology Business Review: Mark T. Fleming, MD, regarding the Aramis study in prostate cancer

Oncology Business Review: Mark T. Fleming, MD, offers his impressions of the LATITUDE study in NDx-HR mCNPC

Oncology Business Review: Mark T. Fleming, MD, on the ARCHES trial in metastatic hormone-sensitive prostate cancer

Oncology Business Review: Nicholas Vogelzang, MD, FASCO, FACP, elaborates on combining checkpoint inhibitors in mCRPC

Oncology Business Review: Nicholas Vogelzang, MD, FASCO, FACP, regarding sipuleucel-T in mCRPC

Oncology Business Review: Nicholas Vogelzang, MD, FASCO, FACP, regarding combination pembrolizumab and olaparib in mCRPC

Oncology Business Review: Nicholas Vogelzang, MD, FASCO, FACP, offers his impression of KEYNOTE 365 in mCRPC

Oncology Business Review: Nicholas Vogelzang, MD, FASCO, FACP, regarding the evolution of ADT in prostate cancer

WCPO-TV: New therapy helping people with lymphoma

American Journal of Managed Care: Dr. Jeff Sharman on Using Precision Medicine to Treat CLL

Targeted Oncology: Data Suggest Potential for Immunotherapy in HCC

Oncology Tube: Can a Rituximab Biosimilar Replace Rituximab

Oncology Tube: Lyra Trial in Newly Diagnosed MM

Oncology Tube: Research Examining Gilteritinib in Newly Diagnosed AML

Oncology Tube: Phase 3 Study Investigating Ibrutinib in Older CLL Patients

Oncology Tube: Outcomes of CAPTIVATE Study

Oncology Tube: Phase 3 Study Investigating Ibrutinib in Younger CLL Patients

Oncology Tube: Rituximab Biosimilars in Follicular Lymphoma

Oncology Tube: The CLL-14 Studies Importane in Determining CLL Treatment Strategies

American Journal of Managed Care: Dr. Robert Rifkin Discusses Barriers, Biomarkers in Multiple Myeloma

American Journal of Managed Care: Dr. Robert Rifkin on Lack of Education Surrounding Biosimilars

OncLiveTV: Dr. Rifkin on Split Dosing of Daratumumab in Myeloma

HemOnc Today: Recent trials impact first-line management of chronic lymphocytic leukemia

American Journal of Managed Care: Dr. Jeff Sharman Discusses Standard of Care for CLL Based on Treatment Setting

American Journal of Managed Care: Dr. Robert Rifkin Outlines Recent Treatment Advances in Multiple Myeloma

Oncology Business Review: Jeff Sharman, MD, shares his thoughts on rituximab biosimilars in follicular lymphoma

Oncology Business Review: Jeff Sharman, MD, on the outcomes of CAPTIVATE study investigating ibrutinib and venetoclax

Oncology Business Review: Jeff Sharman, MD, on how important the CLL-14 study is in determining CLL treatment strategies

Oncology Business Review: Jeff Sharman, MD, discusses the phase 3 study investigating ibrutinib in younger CLL patients

Oncology Business Review: Jeff Sharman, MD, discusses the phase 3 study investigating ibrutinib in older CLL patients

Oncology Business Review: John Burke, MD, elaborates on the BEAT AML umbrella study

Oncology Business Review: John Burke, MD, comments on clinical research examining gilteritinib in newly diagnosed AML

Oncology Business Review: John Burke, MD, elaborates on the incorporation of venetoclax into AML treatment regimens

Oncology Business Review: John Burke, MD, speaks to the reliability of the FLT3 mutation test

Oncology Business Review: John Burke, MD, regarding gilteritinib in acute myeloid leukemia treatment

Oncology Business Review: Robert Rifkin, MD, shares his thoughts on if a rituximab biosimilar can replace rituximab

Oncology Business Review: Robert Rifkin, MD, discusses the rationale for genetically profiling AML patients

Oncology Business Review: Robert Rifkin, MD, explains whether or not anti-BCMA CAR-T cell therapy looks promising

Oncology Business Review: Robert Rifkin, MD, discusses the outcomes of the TOURMALINE-MM3 study

Oncology Business Review: Robert Rifkin, MD, talks about what clinical data could change the way multiple myeloma is treated

Oncology Business Review: Habte Yimer, MD, considers the outcomes of the GRIFFIN study in multiple myeloma

Oncology Business Review: Habte Yimer, MD, speculates on the future of anti-BCMA CAR-T cell therapy

Oncology Business Review: Habte Yimer, MD, regarding the POLLUX and CASTOR studies presented at ASH 2018

Oncology Business Review: Habte Yimer, MD, regarding the Lyra trial in newly diagnosed multiple myeloma presented at ASH 2018

Cancer Therapy Advisor: Results from LYRA Phase 2 Study of Frontline Multiple Myeloma Therapy

Cancer Therapy Advisor: A Potential Rituximab Biosimilar?

Cancer Therapy Advisor: ASH 2018: New Developments in Treatment of Multiple Myeloma

Cancer Therapy Advisor: ASH 2018: Practice-Changing Findings on Treatment of Lymphoma

eCancer: Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma

American Journal of Managed Care: Dr. Scott Paulson: Role of Somatostatin Analogs, Biomarkers in Treatment of GEP-NETs

American Journal of Managed Care: Dr. Marcus Neubauer discusses the evolution of care teams in oncology

Denver ABC 7: Breast cancer survivor’s recovery eased with cold cap that helps prevent hair loss

OncLive TV: Dr. Paulson Discusses the Current Treatment for NETs

Oncology Business Review: Dr. Vogelzang Discusses PROSPECT Trial for Prostate Cancer

Oncology Business Review: Debra Patt, MD on NGS and Cancer: Combatting the Hazards of Misinformation

Oncology Business Review: Debra Patt, MD on Will NGS-Based Cancer Tests Become Routine?

Oncology Buisness Review: Debra Patt, MD on Next-Gen Sequencing is Transforming Oncology Practices

Oncology Business Review: Neelima Denduluri, MD, comments on the role of CDK4/6 inhibitors

Oncology Business Review: Neelima Denduluri, MD, tells us about the recent updates to breast cancer guidelines

Oncology Business Review: Nwelima Denduluri, MD, offers opinion on the PERSEPHONE trial in early HER2+ breast cancer

Oncology Business Review: Neelima Denduluri, MD, on the outcomes of the SANDPIPER study presented at ASCO 2018”

Oncology Business Review: Neelima Denduluri, MD puts the PERSEPHONE trial into context with the Short-HER trial.

Oncology Business Review: Nicholas J. Vogelzang, MD, on imaging as an effective solution for prostate cancer diagnosis

Oncology Business Review: Nicholas J. Vogelzang, MD, offers opinion on how MRI has improved diagnosing in prostate cancer

Oncology Business Review: Nicholas J. Vogelzang, MD, on how we can avoid under-diagnosing & over-diagnosing prostate cancer

Oncology Business Review: Neelima Denduluri, MD on whether taselisib might one day become a standard of care based on the outcomes of the SANDPIPER study.

Oncology Business Review: Neelima Denduluri, MD on the significance of the improvement in the PFS fulvestrant +ribociclib arm of the MONALEESA-3 study in HR+/HER2- advanced breast cancer.

Oncology Business Review: Neelima Denduluri, MD on the practice-changing results of the TAILORx study.

Ecancer TV: ASCO 2018 Conference Round-Up

Ecancer TV: Atezolizumab with Chemotherapy Improves PFS in Squamous NSCLC

OBR Daily: Dr. Robert Rifkin, Medical Director, Speculates on What Might Influence the Adoption of Biosimilars by Oncologists

OncLiveTV: Therapy Selection in BRCA-Mutated Ovarian Cancer (Panel video with Bradley J. Monk, Arizona Technology, The Network)

OncLiveTV: Adopting Neoadjuvant Therapy into Ovarian Cancer (Panel video with Bradley J. Monk, Arizona Technology, The Network) 

OncLive TV: Implications for Germline BRCA Testing in Breast Cancer (panel hosted by Dr. Joyce O’Shaughnessy)

OBR Daily: Debra Patt, MD, MPH, MBA, Explains the Benefits and Challenges Associated with Prescribing CAR-Ts

Oncology Business Review: Michael Seiden, MD, PhD, tells us how big data is helping to advance clinical progress

OncLive TV: Adjuvant Sunitinib’s Role in the Treatment of RCC

American Journal of Managed Care: Dr. Linda Frisk Discusses the Role of the Pharmacist in Value-Based Care

OncLiveTV: Dr. Paulson on the Importance of Symptom Control

Oncology Tube: FDA Approval of Several CAR-T Cell Therapies – Hope to make new therapies accessible to patient

Oncology Tube: Development of a Predictive Model of MM Patient Outcomes – Based on Treatment Class Transitions using patient registry

Oncology Tube: Baseline Disease Characteristics & Diagnostic Patterns for NDMM – Observations over time in Cohort 1 and Cohort 2

Oncology Tube: Survival and Depth of Response in African American and Non-AA Patients – Conflicting data on the virulence of Myeloma for African American patients

Oncology Tube: Connect® Multiple Myeloma Patient Registry – Eventually pool data from Connect® for a larger database of registry

Oncology Tube: Carflizomib is Extraordinarily Active in Myeloma Mainstay drug for physicians and patients

Oncology Tube: Carflizomib Doing Patterns – Data presented for appropriate dosing of Carfilzomib

Oncology Tube: Poster #1 Phase 2 Study of Daratumumab+ CyBorD – Dose was split into two days to reduce infusion time

Oncology Business Review: Robert M. Rifkin, MD, on excluding transplantation from MM treatment algorithms

Oncology Business Review: Robert M. Rifkin, MD, discusses if COMPASS is close to its goal of achieving whole genome sequencing

Oncology Business Review: Robert M. Rifkin, MD, on the Connect Multiple Myeloma patient registry improving characterization

Oncology Business Review: Robert M. Rifkin, MD, on how the Connect Multiple Myeloma patient registry is helping patients

Oncology Business Review: Michael Boxer, MD, on how obinutuzumab and bendamustine impacts quality of life in CLL patients

Oncology Business Review: Michael Boxer, MD, considers broader uses for fostamatinib

Oncology Business Review: Michael Boxer, MD, on the effectiveness of fostamatinib in the maintenance of ITP responses

Oncology Business Review: Habte Yimer, MD, on daratumumab, cyclophosphamide, bortezomib, & dexamethasone in relapsed MM

Oncology Business Review: Habte Yimer, MD, considers the impact of combination obinutuzumab and bendamustine on CLL patients

Oncology Business Review: James Essell, MD, discusses the concerns for patients receiving allogeneic transplantations

Oncology Business Review: James Essell, MD, on how allogeneic transplantation is incorporated into hematologic malignancy

Oncology Business Review: John Burke, MD, on rituximab as an effective strategy after 1st line bendamustine-rituximab in FL

Oncology Business Review: John Burke, MD, lists the top findings from ASH 2017 regarding lymphoid malignancies

Oncology Business Review: John Burke, MD, on combination atezolizumab, obinutuzumab, and bendamustine in follicular lymphoma

KTNV-TV: Advances in brain cancer treatment gives patients new hope

Oncology Business Review: Debra Patt, MD, considers how community oncology contributes to clinical research advancement

Oncology Business Review: Debra Patt, MD, shares how community oncology has contributed to advances in population health

Oncology Business Review: Debra Patt, MD, elaborates on how community oncology contributes to the Cancer Moonshot

Oncology Business Review: Ben Jones shares what McKesson Specialty Health is doing to help community oncologists thrive

Oncology Business Review: Ben Jones gives advice to practices interested in advocating for community oncology

Oncology Business Review: Ben Jones on the hot policy topics impacting the delivery of quality cancer care

Oncology Business Review: Lalan Wilfong, MD, explains how OCM has impacted cancer patients in his practice

Oncology Business Review: Lalan Wilfong, MD, provides opinion on how OCM is changing his practice

Oncology Business Review: Lalan Wilfong, MD, shares lessons from his experience participating in OCM

Oncology Business Review: Debra Patt, MD, on technological advances in cancer care and community oncology

Oncology Business Review: Debra Patt, MD, on what tele-health brings to cancer care

Oncology Business Review: Debra Patt, MD, explains how data systems help with patient care delivery in community oncology

Oncology Business Review: Debra Patt, MD, explains how decision support tools improve the quality and delivery of cancer care

Oncology Business Review: Debra Patt, MD, explains using predictive analytics to improve cancer care delivery

Oncology Business Review: Diana Verrilli, McKesson Specialty Health, on how claims data can be used in the OCM model

Oncology Business Review: Diana Verrilli, McKesson Specialty Health, on how claims data is being used

Oncology Business Review: Marcus Neubauer, MD, discusses how practices and administrators can build higher pathway compliance

Oncology Business Review: Marcus Neubauer, MD, explains how clinical pathways differ from clinical guidelines

Oncology Business Review: Marcus Neubauer, MD, discusses if clinical pathways create value in cancer care

Oncology Business Review: Marcus Neubauer, MD, explains how clinical pathways save money when treating cancer

Patient Power: ASH 2016 Expert Roundtable: What does emerging CLL research mean for patients?

Oncology Tube: ASH 2016 Lymphoma News

OncLiveTV: Dr. Kolibaba on Efficacy of Entospletinib in Mantle Cell Lymphoma

OncLiveTV: Dr. Kolibaba on Entospletinib Activity in Mantle Cell Lymphoma

OncLiveTV: Dr. Kolibaba on Mechanism of Action with Entospletinib in MCL

OncLiveTV: Dr. Burke on a Study Investigating Obinutuzumab in Large B-Cell Lymphoma

healtheo360: Vital Conversations: David J. Andorsky from Rocky Mountain Cancer Centers (Part 1 of 2)

healtheo360: Vital Conversations: David J. Andorsky from Rocky Mountain Cancer Centers (Part 2 of 2)

healtheo360: Vital Conversations: Dr. Jeff Sharman from the Willamette Valley Cancer Institute and Research Center

healtheo360: Vital Conversations: Dr. Kathryn Kolibaba from Compass Oncology

healtheo360: Vital Conversations: Dr. John Burke from Rocky Mountain Cancer Centers

HemOnc Today: Symposium highlights diversity of breast cancer biology, targets

HemOnc Today: Genomic profiling may identify subset of women who benefit from extended letrozole

HemOnc Today: Combination active in subset of women with triple-negative breast cancer

HemOnc Today: Anti-CD19 CAR T cells may offer new option for difficult-to-treat patients with DLBCL

Patient Power: ASH 2016: Hodgkin Lymphoma News

Patient Power: ASH 2016: Lymphoma Research News Update

OncLiveTV: Dr. Blum on Takeaways from ABC Trials for Breast Cancer

OncLiveTV: Dr. Nicholas Robert on MA.17R Trial for Patients With Early-Stage Breast Cancer

Oncology Business Review: Debra Patt, MD, tells us how chemotherapy costs figure into total care

Patient Power: ASCO 2016 CLL Research Update

Patient Power: 2016 Lymphoma Research Update

Patient Power: ASH 2015: What Could a Second-Generation BTK Inhbitor Mean for Patients?

Patient Power: ASH 2015 Coverage: Emerging Approaches for Treatment-Resistant CML Patients

Patient Power: ASH 2015 News: Emerging Approaches for Elderly Hodgkin Lymphoma Patients

Patient Power: Dr. Jeff Sharman: My Perspective on ASH 2015 News

Patient Power: Follicular Lymphoma News From ASH 2015

OncLiveTV: Dr. Sharman on Entospletinib in Patients with CLL

OncLiveTV: Dr. Joanne Blum on the EMBRACA Trial in Metastatic BRCA-Mutant Breast Cancer

OncologyTube: Ibrutinib or Idelalisib Selecting Appropriate Therapy for Relapsed CLL

OncologyTube: Entospletinib Why It’s Different Than Fostamatinib

CLL Transformed in Last 5 Years, Hope is to Leave Chemotherapy Behind

OncologyTube: Bcl-2, BTK, and PI3 Inhibitors Among Highlights Presented at ASH 2015

Patient Power: Advances in Treating High-Risk CLL

The Today Show: Hope to it

Patient Power: What Could Emerging Immunotherapy Research Mean for Lung Cancer Patients

Patient Power: Advances in Immuno-Oncology Research

OncLiveTV: Dr. Spira on the POPLAR Study NSCLC

Fox News: Hospitals being overpaid for medical treatment?

CBS Evening News: Consumer protection on Obamacare delayed

OncLiveTV: Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer

OncLiveTV: Role of Lapatinib in HER2-Positive Breast Cancer

OncLiveTV: Dr. Vogelzang on Two Analyses of the ALSYMPCA Trial

OncUView TV: ASCO 2013 – Nicholas Vogelzang, MD, discusses Xofigo (radium Ra 223 dichloride)

OncLiveTV: Dr. O’Shaughnessy on Everolimus in Breast Cancer

OncLive TV: Managing Bone Health in Metastatic Breast Cancer

OncLiveTV: Ben Jones on the Impact of Sequestration on Reimbursement

KTNV-TV ABC 13 : Partial Breast Radiation Therapy

The Today Show: Family faces breast cancer together

WUSA9: Dr. Neelima Denduluri, Virginia Cancer Specialists, Discusses Fears Over Chemotherapy After Roberts’ Announcement

ABC 15: Screening still vital in prostate cancer, Arizona doctor discusses treatments

PBS News Hour: Drug Hoarders, Manufacturing Cuts Exacerbate Shortage of Key Medications

Inside Business Reports: Advancements in Cancer Treatment and Care

21st Century Health: Innovative Cancer Treatment Solutions

WFMJ-TV NBC: Providing cancer treatment to those who cannot afford it

Bloomberg: McKesson to purchase US Oncology

Radio

Bark & Wag: Dr. Curtis Mack shares his story on how his dogs helped him fight cancer

Health Professional Radio: The San Antonio Breast Cancer Symposium 2017

Health Professional Radio: NERLYNX – Breast Cancer Treatment

Health Professional Radio: NERLYNX Update

The Tom Joyner Morning Show: Get Well Wednesday: Dr. Tia Olds Answers your Cancer Questions

Articles

Pharmacy Times: Lung Cancer Study Bring Pharmacists to the Forefront of Patient Care

Targeted Oncology: Using Real-World Data to Understand the Impact of COVID-19 on Oncology Patient Care

Precision Medicine Will Drive New Standards of Care in the Post-COVID-19 World

New U.S. health crisis looms as patients without COVID-19 delay care

Early Data Suggest Acalabrutinib May Benefit Patients With Advanced COVID-19

Blood Test Detects Over 50 Different Cancers With a 0.7% False-Positive Rate

Proton Therapy Improves Outcomes, Reduces Radiation Side Effects in Patients with Cancer

Don’t Delay Cancer Care During COVID-19 Crisis

Platinum-Sensitive, Recurrent Ovarian Cancer: Trial of Surgery + Chemo With and Without Bevacizumab

OncLive: Homing in on Targeted Treatment Strategies in Breast Cancer

OncLive: Breast Oncologists Aim to Address Key Unanswered Questions With Novel Research Efforts

Oncology Nursing News: Personalized Treatments, HER-Directed Drugs Are Changing The Breast Cancer Space

American Journal of Managed Care: Clinical Pathways: Reducing Costs and Improving Quality Across a Network

OncLive: Advanced Practitioners Improve Quality Care Value

Targeted Oncology: O’Shaughnessy Discusses Emerging Data That Could Affect TNBC Treatment Options

OncLive: The FDA Could Help Address Financial Toxicity During the Approval Process

OncLive: Can New Oncology Payment Programs Help Stabilize Medicare?

Women: Three Things you can do to Prevent Breast Cancer

Women’s Health: 10 Subtle Signs Of Breast Cancer That Have Nothing To Do With Lumps

Fox 7 News Austin: Breast Cancer Awareness Month: New BRCA gene mutation guidelines

Modern Healthcare: Minnesota Blues strikes up outcomes-based cancer care arrangement

Managed Healthcare Executive: Innovative Risk-Based Arrangement Could Change Cancer Care

Journal of Clinical Pathways: The US Oncology Network and Clinical Pathways in the Evolving Landscape of Cancer Care

Journal of Clinical Pathways: High-Quality Care in Multi-Site Networks: Implementing a Centralized Pharmacy and Pathways

The Columbian: For two moms with breast cancer, it was all about weathering the storm

Las Vegas Review Journal: Las Vegas Mayor Carolyn Goodman shares story of cancer fight

American Journal of Managed Care: Lessons From the Field: How Practices Are Succeeding Under OCM

American Journal of Managed Care: How Obesity Affects Cancer Treatment, and How to Talk to Patients About Prevention

Targeted Oncology: Expert Discusses Challenges With Checkpoint Inhibition in the Frontline Treatment of Metastatic Bladder Cancer

Radiology Today: Lack of Awareness: Proton therapy shows promise and value for many cancers, but hurdles to wider use remain

OncLive: CMS Should Broaden Coverage for Germline Mutation Testing

HealthTech: How Are Predictive Analytics Applications Changing Oncology?

OncLive: Vogelzang Highlights Decades of Innovation in Prostate Cancer

American Journal of Managed Care: Who’s Next in Line for New Payment Models? Everybody!

Oncology Practice Management: Decision Time Is Approaching for Practices in the Oncology Care Model

ASCO Daily News: Surging Ahead: Oncologists Pivot to Keep Cancer Treatment Moving in the Wake of Hurricane Michael

ASCO Daily News: Rituximab/Lenalidomide Regimen Shows Clinical Benefit in Non-Hodgkin Lymphona Trials

OncLive: Proton Therapy: A Path to Improved Outcomes and Quality of Life

OncLive: Efficacy Data Support Acalabrutinib Across CLL Settings

Oncology Business Review: Forecasting Interview: Michael Seiden, MD, PhD, President, The US Oncology Network

HelloGiggles: Your questions about ovarian cancer answered: from early symptoms to treatment

OncLive: Personalized Medicine Progressing in Premenopausal Breast Cancer

The ASCO Post: Lenvatinib Plus Pembrolizumab Shows Activity in Advanced Urothelial Cancer

OncLive: Practical Treatment Questions Surface in HR-Positive Metastatic Breast Cancer

Targeted Oncology: Ibrutinib Survival Outcomes in MCL Consistent in Real-World Setting, But Questions Remain

OncLive: What’s Keeping CAR T-Cell Therapies From the Outpatient Setting?

American Journal of Managed Care: Keeping Ahead of the Curve in the Transition to Oncology Value-Based Payment

CURE: Split Dosing Has Comparable Results in Myeloma Treatment

Targeted Oncology: Expert Shares Data for Split Dosing Schedule of Daratumumab in Multiple Myeloma

OncLive: Real-World Ibrutinib Survival Data in MCL Consistent With Clinical Trials

OncLive: Real-World Evidence Supports Split Daratumumab Dosing in Myeloma

Oncology Practice Management: MIPS: How to be successful today and in the future

OncLive: Developing Alternative Payment Models that Providers and Commercial Payers Support

OncLive: Luminary Awards in GI Cancers Honor Distinguished Leaders

The Columbian: Vancouver doctor in select company having completed 1,000th robot surgery

American Journal of Managed Care: Keeping ahead of the curve in the transition to oncology value-based payment

Nature: Precision therapies take aim at non-Hodgkins lymphoma

Las Vegas Review-Journal: Healthy lifestyle, diet reduce risk of cancer

Las Vegas Review-Journal: New treatments bring hope to patients

Journal of Clinical Pathways: Evolving the Delivery of CAR-T Cell Therapies to the Outpatient Setting

Zwivel: What Is Male Breast Cancer? Symptoms, Causes, and Treatment

Becker’s Hospital Review: Understanding the Future Cancer Patient

OncLive: A Perfect Storm Brews for Biosimilar Marketing

American Journal of Managed Care: Review Finds Mixed Results for APMs and New Care Delivery Models in Cancer

Women: Three things you can do to prevent breast cancer

Las Vegas Sun: Golden Knight Pierre-Edouard Bellemare’s family connects with Comprehensive Cancer Centers

CURE Today: From Bedside to Patient to Caregiver: One Oncologist’s Story of Each Side of the Cancer Journey

Targeted Oncology: Novel Agents are Changing the Face of Metastatic TNBC

Oncology Practice Management: Dispelling Misconceptions about HCC Coding

PM360: Solving the Adherence Problem

Oncology Practice Management: Strategic Planning by Oncology Practices Can Provide a Roadmap to a Thriving Future

Pharma Commerce: Oncology pathways reconcile standardization with personalization quotes Dr. Neubauer

American Journal of Managed Care: Challenges with Treating Merkel Cell Carcinoma and Other Rare Diseases

Rare Disease Report: Exploring Treatment Challenges for Merkel Cell Carcinoma & Other Rare Cancers

CURE: Erdafitinib Shows Promise in Advanced FGFR-Positive Bladder Cancer

CURE: The Center of Attention

OncLive – Dr. Jotte on the IMpower131 Findings in Squamous NSCLC

UroToday: ASCO 2018 – First Results from the Primary Analysis Population of the Phase 2 Study of Erdafitinib in Patients with Metastatic or Unresectable Urothelial Carcinoma and FGFR Alterations

UroToday: ASCO 2018 – Pembrolizumab Versus Investigator’s Choice (Paclitaxel, Docetaxel, or Vinflunine) in Recurrent, Advanced Urothelial Cancer: 2-Year Follow-Up from KEYNOTE-045 Trial

Endpoints News: UPDATED: Roche Boasts of Stalling Lung Cancer with Tecentriq/chemo Combo — but Rival Merck Stays Out Front

American Journal of Managed Care: Utilization Management in Oncology: Current Strategies and a Path Forward

STAT News: Grail’s Cancer Blood Test Shows ‘Proof of Principle,’ but Challenges Remain

MedPage Today: Checkpoint Blocker Plus Chemo Slows NSCLC Progress – No Significant OS Improvement in Interim Analysis of IMpower131 trial

OncLive: Atezolizumab Plus Chemo Extends PFS in Frontline Squamous NSCLC

BioPharma Dive: ASCO18 – Tecentriq Scores Again in Lung cancer, but Keytruda Looms in Background

CURE: Ounce of Lung Cancer Prevention, Worth a Pound of Cure

Targeted Oncology: Improved PFS Shown With Atezolizumab Plus Chemo for Frontline Squamous NSCLC in IMpower131 Trial

GenomeWeb: Advanced NSCLC Trials Demonstrate Potential of First-Line Immunotherapy

UroToday: ASCO 2018 – SPEAR-Bladder (Study Informing Treatment Pathway Decision in Bladder Cancer): First-Through Third-Line Time to Treatment Failure in the US

Cancer Network: PFS Boost with Atezolizumab in Advanced Squamous NSCLC

HemOnc Today: First-Line Atezolizumab Improves PFS for Advanced Squamous Non-Small Cell Lung Cancer

Medscape: Top 5 Lung Cancer Presentations at ASCO 2018

Oncology Business Review:: ASCO Highlights for Saturday, June 2, 2018

Uro Today: ASCO 2018: Sipuleucel-T OS and Clinical Outcomes by Baseline PSA Quartiles in Patients with mCRPC: PROCEED Registry

OncLive: 5 Key Elements Needed to Achieve Success With the Oncology Care Model

PM360: Four Key Questions about Payer/Provider Strategies

American Journal of Managed Care (AJMC): Panelists Discuss Key Issues in Community Oncology Affecting Patients and Practices

Journal of Clinical Pathways: From Clinical Use to Reimbursement: An Update on Biosimilars in the US

OncLive: A Collaborative Model for Advanced Practice Providers Empowers Success

Journal of Clinical Pathways: Texas Oncology, Aetna Collaborate to Improve Patient Care Through Clinical Pathways

Journal of Clinical Pathways: Ehancing Care Coordination Supports Transition Toward Value-Based Care

Targeted Oncology: Panelists Highlight Ways to Ease Transition to Value-Based Care

Managed Healthcare Executive: Seven diseases benefiting from genetic tests

OncLive: Classification of Triple Negative Breast Cancer

The Hill: Unequal Medicare Payments Fuel Health Care Consolidation Trends

OncLive: Patient Collaboration Can Help Solve “Crisis” in Cancer Care

Oncology Business Review: Nicholas J. Vogelzang, MD Considers Genomics and Systemic Therapy in Advanced Prostate Cancer

Cure: FDA: Approves Frontline Verzenio for Advanced HR-Positive, HER2-Negative Breast Cancer

OncLive: FDA Approves Frontline Abemaciclib for HR+/HER2- Advanced Breast Cancer

CURE Today: The History Behind the Development of CAR-T Cell Therapy

Radiology Today: Managing to Succeed: Advancing Value-Based Cancer Care

OncLive: Keeping a Tight Rein on Unnecessary Expenditures in Oncology Practice

CURE Today: MSI-H Status: What you need to know

ASH Clinical News: What are Biosimilars?

HemOnc Today: Addition of daratumumab to chemotherapy doubles PFS in transplant-ineligible newly diagnosed myeloma

Oncology Times: Development of Neratinib for Early-Stage HER2+ Breast Cancer Patients

OncLive: Von Hoff’s Quest for a Cure in Pancreatic Cancer

The ASCO Post: Where Are We Now in Triple-Negative Breast Cancer?

Managed Healthcare Executive: Four oncology treatment advances to watch

Specialty Pharmacy News: CMS’s Oncology Care Model Has Issues, But Participants Say Care Has Improved

HemOnc Today: WHO creates pilot program to use biosimilars to address ‘prohibitively expensive’ cancer drugs

HemOnc Today: The US Oncology Network boot camp provides expertise, gathers feedback about value-based care

OncLive: Angiogenesis Inhibitor Tested in Mesothelioma Trial

Oncology Business Management: Artificial Intelligence Is Still a Long Way From Understanding the Subtlety of a Texas Metaphor

Oncology Times: Managing the Complexities of Cancer Care With Information Technology

Oncology Business Management: MedPAC’s Latest Part B Proposals Would Raise the Cost of Care

Morning Consult: Modernize Medicare With Site Neutral Payment

Morning Consult: Medicare Proposal to Better Align Payments Deserves Broad Support

Las Vegas Review-Journal: New treatments give hope to patients with tumors like McCain’s

Targeted Oncology: O’Shaughnessy Shares Novel Therapeutic Strategies for Treating Metastatic TNBC

OncologyLive: From Bench to Bedside: O’Shaughnessy Keeps Patients in Focus

OncologyLive: Novel Therapeutic Strategies for Metastatic TNBC

HemOnc Today: Supreme Court ruling on biosimilars ‘a win’ for patients

HemOnc Today: Unknowns of interchangeability likely not problematic with monitoring, FDA guidance

Pharmaceutical Commerce: New science energizes the cancer market

CenterWatch: US Oncology Research, Epizyme collaborate

HemOnc Today: Perspective – Tailored breast cancer survivorship plans improve implementation, adherence

Las Vegas Business Press: Comprehensive Cancer Centers holds rare clinical trials

Vancouver Business Journal: Compass Oncology: Serving community with cutting-edge treatment

Oncology Practice Management: Best Practices in Oncology an Evolving Process

American Journal of Managed Care: Oncologists Believe Achieving Cancer Moonshot Goals Should Start in the Community

HIStalk: Carrot or Stick? Physician Compensation in Value-Based Cancer Care Delivery

Oncology Nursing News: Diagnosing and Treating Patients with Neuroendocrine Tumors and Carcinoid Syndrome

WVEC-TV: Clinical trials expand treatment options for cancer patients in Hampton Roads

ACCC Buzz: What Happened in Vegas: Highlights from the 2017 Cancer Center Business Summit

Las Vegas Review-Journal: Beloved doctor Nicholas Vogelzang won’t stop fighting cancer

E News: Shannen Doherty completes radiation therapy and pays tribute to another cancer doctor and “Maggie”

Oncology Business Management: Joining Forces Without Loss of Independence

Oncology Practice Management: Physician-Owned, Community-Based Oncology Practices: The US Oncology Network Model

Managed Healthcare Executive: Watch list 2017: Top therapeutic areas

Specialty Pharmacy News: CMS Launches ‘Transformative,’ ‘Monumental’ Oncology Care Model

Denver Business Journal: Denver doctor on leading edge of treating neuroendocrine cancer

U.S. News & World Report: What to Look for in a Hospital if You Need Lung Cancer Surgery

U.S. News & World Report: Stomach Cancer: Awareness and Advances Needed

HIStalk: Physician Engagement in Cancer Care Delivery Redesign

OncologyLive: Oncology Practice Vitality Depends on Leadership

Lung Disease News: Center Enrolls First Lung Cancer Patient in Advanced Phase 3 Clinical Trial

Specialty Pharmacy News: With CMS’s OCM Set to Start July 1, The US Oncology Network Preps Practices

HealthLeaders: Oncology Care Model Kicks Off

Targeted Oncology: Anthracycline Regimen Superior in HER2-Negative Breast Cancer

The Hill: Congress: Don’t dial back site-neutral payment reforms

STAT News: Breast cancer study shows benefit to extended treatment with aromatase inhibitors

Oncology Business Management: Some Prefer Pay Cuts to Inflexible CMS Metrics

Oncology Nurse Advisor: Anthracycline-based Regimens Superior in Treating High-Risk, HER2-negative Breast Cancer

Pharmaceutical Commerce: Oncology: a new era in therapies; same cost concerns

Managed Healthcare Executive: New oncology payment model accelerates shift to value

ASCO Connection: Five Difficult Interview Questions Oncology Fellows May Encounter: The Do’s and Don’ts

Prevention.com: 7 Worst Things People Lie To Their Doctors About

Reader’s Digest Online: 17 Common Lies You Tell Your Doctor (And Why You Need to Just Stop)

HIStalk: Empowering Value-Based Technologies with Standardization, Agreement, and Leadership

Oncology Business Management: Top 3 Must Do’s to Prepare for Managed Care in 2016

HealthLeaders: Oncology Bundling Model Aims to Incentivize Doctors

SheKnows.com: Signs your migraine is more than just a minor headache

SheKnows.com: Nine health myths about your boobs you can finally put to rest

Ocala Star Banner: Promising new cancer drug helping Ocala woman

OncologyLive: Oncologists Must Take Lead Role in Developing Clinical Pathways

Oncology Times: ASCO Issues Recommendations to Improve Oncology Clinical Pathways

OncologyLive: Tackling Challenging Patient Populations in DLBCL

OncologyLive: Frontline Brentuximab Vedotin Generates 76% Complete Remission Rate in DLBCL

HemOnc Today: Brentuximab vedotin combinations yield encouraging response rates in elderly Hodgkin’s lymphoma

Oncology Business Management: Compatibility Check: Can Precision Medicine and Pathways Co-Exist?

Oncology Business Review: Extending and Enhancing Patient Care Beyond the Office with Patient Portals

Fox News: Moms with BRCA breast cancer gene mutations face tough decisions

Oncology Times: Critiquing ASCO’s Cancer Care Value Plan

HealthDay News: Could Common Diapetes Drugs Help Fight Leukemia?

LiveScience.com: Skeletal System: Facts, Function & Diseases

HealthDay: 1 in 3 Women Survive Ovarian Cancer a Decade or More: Study

OncologyLive: O’Shaughnessy Details Strategies to Strengthen ER Blockade in MBC

Oncology Business Management: CMS Standards for Reporting Call for Advanced Technology, Training

OncologyLive: Shifting Reform Landscape Is Perilous for Small Practices

HealthDay News: Cell Damage Occurs When People Have CT Scans: Study

LiveScience.com: Lymphatic System: Facts, Functions & Diseases

Yahoo!: One Woman’s Story Highlights the Hidden Skin Cancer Risks for People of Color

U.S. News & World Report: Preparing for a Baby After Cancer

Everyday Health: First Breast, Now Lung: One Woman’s Fight Against Cancer

Oncology Business Management: Physician Quandary: Data Shortage, Surfeit Impinge on Precision Medicine

Oncology Business Management: More Effort Needed to Understand Value Breadth of Molecular Testing

Managed Care: Biosimilars Change the Market But Still Face Many Hurdles

BlackDoctor.org: Condition Critical: Fighting Breast & Cervical Cancers In Black Women

Roll Call: A Common-Sense Medicare Solution: Site-Neutral Payment Reform | Commentary

Examiner.com: Joel M. Schwartz, DO increases your knowledge regarding skin cancer awareness

Oncology Times: CLL: New Drugs Bring Paradigm Shift for High-Risk Disease

Specialty Pharmacy Continuum: Cancer Drugs Help SPs Show Their Value

Oncology Business Review: Novel Therapies for Leukemia Attract Attention at ASCO 2014

Bloomberg: Bristol-Myers, Merck Immune Therapy Promising in Cancer Trials

BioNews Texas: New Clinical Trial By US Oncology Research Tests Chemotherapy-Induced Hair Loss Therapy

Albany Business Review: Former executive at Albany area’s largest cancer-treatment center gets regional position

HealthDay News: Popular Crohn’s, Colitis Drugs Not Linked to Short-Term Cancer Risk: Study

The New York Times: Study May Alter Approach to Prostate Cancer

OncologyLive: Vogelzang Sees Early Chemo Strategy as Landmark Change in Prostate Cancer Therapy

Portland Business Journal: Oregon docs find good news with cancer risk assessment

BioNews Texas: Gastrointestinal Cancers Studied Using Caris Life Science’s Technology, Presented at ASCO Meeting

Las Vegas Review-Journal: Cancer anxiety a factor in treatment

Roll Call: It’s Time to Level the Playing Field in Cancer Care

Pharmaceutical Commerce: Bending the cost curve in oncology

The Journal of Community and Supportive Oncology: Taking on racial and ethnic disparities in cancer care

HealthDay News: New Colon Polyp Removal Method May Be Easier on Patients

HealthDay News: HPV-Linked Oral Cancers May Not Be ‘Contagious’

Forbes: Death Rates From Pancreatic Cancer Continue To Climb: Most Other Cancers Declining In Europe

Forbes: Is There A Link Between Prostate Cancer And Chronic Inflammation?

Forbes: Improved Survival For Men With Localized Prostate Cancer: Six Months Hormonal Treatment Combined With Radiation

HealthDay News: Experimental Breast Cancer Drug Seems Safe, Effective for Advanced Disease

The Cancer Letter: What the Physician Pay Report Won’t Tell You

Modern Healthcare: Denying access to big cancer centers may undermine narrow networks

Forbes: New Urine Test Accurately Predicts Recurrence Of Bladder Cancer

Forbes: Guideline Updated Regarding Role of Sentinel Lymph Node Biopsy In Early Stage Breast Cancer

HealthDay News: Targeted Radiation Might Help Fight Advanced Breast Cancer: Study

HealthDay News: New Guidelines Might Limit Need for Lymph Node Removal for Breast Cancer

HealthDay News: Colon Cancer Cases Decline for Older Americans

Forbes: How Should We Manage Early Prostate Cancer?

OncologyLive: Study Supports First-Line Eribulin Therapy in Metastatic Breast Cancer

HealthDay News: Ovarian Cancer Gene May Point to Early Removal of Ovaries: Study

OncologyLive: PARP Inhibitor BMN 673 Advances in Breast Cancer Study

HealthDay News: Ovarian Cancer Gene May Point to Early Removal of Ovaries: Study

OncologyLive: PARP Inhibitor BMN 673 Advances in Breast Cancer Study

The Hill: Equalize payments for cancer care

Forbes: Cervical Cancer: Detectable and Preventable

Community Oncology: Policy prescriptions to fix our ailing delivery system

Forbes: Novel Genetic Test For Breast Cancer May Guide MRI Screening In Women With Intermediate Lifetime Risk

HealthDay News: Experimental Vaccines May Extend Life in Pancreatic Cancer

HealthDay News: Blood Test Might Help Spot Pancreatic Cancer Early

Las Vegas Review-Journal: Brave risk helps women cheat death

Value-Based Cancer Care: New Collaborative Advance Care Planning Program for Patients with Cancer Enhances Quality while Mitigating Costs

Roll Call: Cancer Care Rests in the Community — and in Logical Medicare Payment Policies | Commentary

BioNews Texas: Austin’s XBiotech Set To Launch Phase III Trial Collaboration with US Oncology Research for Anti-Cancer Drug Xilonix

Las Vegas Review-Journal: Survivor spirit: Summerlin mom makes most of life after Stage 4 breast cancer

Modern Healthcare: Seiden named CMO of McKesson division, oncology group

The Washington Post: Oncofertility offers new options for young women with cancer who want to have kids

Managed Care: Health Plans Lag Providers On Molecular Profiling

Vegas Inc: Patient profile: A conversation with Paul Bodner

MedPageToday: Oncology Clinics Caught in Financial Vise

The Health Journal : Genetic Testing: Knowing The Family Tree and Family Genes

Specialty Pharmacy News: Molecular Diagnostics Initiative Should Improve Care, Reduce Costs

MedPage Today: No Excess Risk of AML, MDS after Chemo

Cancer Network: ASCO Breast: DNA-Damaging Therapies Emerging as Possible Triple-Negative Breast Cancer Therapies

The Courier of Montgomery County: McKesson, US Oncology employees make 750 care packages for military

Medscape: The Right EHR for an Oncology Practice

Oncology Times: Pathway or Pathways? Major Pennsylvania Insurer Takes a Stand, But Now a Long-Time Partnership Has Turned Difficult

Biotechnology Healthcare: Will Clinical Pathways Work?

The New York Times: Insurers Test New Cancer Pay Systems

The Wall Street Journal: In Treating Cancer, Insurer Tries New Way to Pay Docs

Chicago Tribune: Patient Assistance Support

Bureau of National Affairs: BNA Q & A: Risk Contracting Model for Oncologists and Payers

HemOnc Today: Small cell lung cancer requires complex therapeutic strategies

Tyler Morning Telegram: Clinical Trials Pivotal In Drug Development

Information Week: BI Made Easier For Healthcare

Odessa American Daily: Clinical Trials

HemOnc Today: REMS for ESAs: The FDA mandated program is under scrutiny

HemOnc Today: Hematologic Malignancies

Cancer Network: Evidence-based pathway plus electronic health records system matches major trials for colorectal cancer treatment outcomes

North Bay Business Journal: Redwood Regional joins nationwide network of oncologists

Houston Business Journal: Collaboration Creates Cancer Center

Woodlands Online: Memorial Hermann, Texas Oncology And US Oncology Partner

Las Vegas Review Journal: TREATMENT QUALITY: Care, research attract visitors

Dallas Morning News: Cancer doctors weigh in with opinions on travel

Dallas Morning News: The trip treatment: Traveling during cancer care

Oncology Times: Cancer Care Pathways Catching on with Payers

Pharmawire article on Celgene’s Revlimid

Pharmawire article on melanoma May 2010

Houston Business Journal: US Oncology unveils new brand campaign

Pharmawire article: Poniard pushes forward with picoplatin in small cell lung cancer despite prior failure; oncologists cautious about success

Pharmawire article: Abraxis: Abraxane must show major clinical benefit over generic paclitaxel for widespread use, physicians say

Pharmawire article: Eisai and Supergen’s Dacogen expected to demonstrate positive results in DACO-016 trial in AML, hematologists/oncologists say

Pharmawire article: Sunesis’ voreloxin offers modest response rates, but encouraging toxicity in AML – hematologists

Wall Street Journal article Women’s Health

Nevada Business Magazine: Nevada Business Magazine – Healthcare Heroes

James Kilber profile for Top Administrator in Southern Nevada (page 7)

Nevada Business Magazine: Nevada Business Magazine – Healthcare Heroes

Dr. Mary Ann Allison profile for Caregiver of the Year in Southern Nevada (page 8)

Tampa Bay Times: Florida Cancer Affiliates opens site in New Port Richey

US News & World Reports: Experimental Drugs Do Battle Against Advanced Prostate Cancer

Reuters: Breast cancer kills older women more often

Studies

The New England Journal of Medicine: Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

The New England Journal of Medicine: Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

The New England Journal of Medicine: Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Journal of Oncology Practice: Opening the Black Box: The Impact of an Oncology Management Program Consisting of Level I Pathways and an Outbound Nurse Call System

The New England Journal of Medicine: Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

The New England Journal of Medicine: Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

Managed Care: Molecular Monitoring of Response In Patients With Chronic Myeloid Leukemia

Journal of Oncology Practice article: Cost Effectiveness of Evidence-Based Treatment Guidelines for the Treatment of Non–Small-Cell Lung Cancer in the Community Setting

Podcasts

American Journal of Managed Care: Exploring the Rise of Obesity-Related Cancers: A Conversation With Dr. Debra Patt

Oncology Business Review: Ovarian Cancer-Bradley Monk, MD, and Robert Figlin, MD, provide post ESMO ’19 clinical update

Oncology Business Review: Breast Cancer-Neelima Denduluri, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO 2019

ASCO Daily News: Dr. Karen Tedesco Discusses How the IMpassion130 Study Will Inform Metastatic Triple-Negative Breast Cancer Care

Journal of Clinical Pathways Podcast: Current and Potential Significance of Real-World Data in Value-Based Outcomes, Compliance

Journal of Clinical Pathways: OCM Pilot Program Successes at The US Oncology Network

Podcast from HemOncTown eNews featuring US Oncology Chief Scientific Officer Daniel Von Hoff, M.D., F.A.C.P.

 

Blogs

Responding to Coronavirus, Cancer Researchers Reimagine Clinical Trials

mcolBLOG: Getting More Precise About Precision Medicine

Software Advice: US Oncology iKnowMed EHR Medical Software

ASCO 2010-Cabazitaxel second line for prostate castration resistant cancer